Francois Cedric

Chief Executive Officer

1 company

Excellent

Trades Analyzed

12M Win Rate

93.3%

Avg 3M Return

+7.6%

Avg 12M Return

+36.0%

Francois Cedric is a Chief Executive Officer at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 16 sells.

Estimated insider holdings value: $19.8M based on current market prices.

Holdings by Company

APLSJan 28, 2026

Current Shares482.0K

Value$19.77M

Net Activity-1,156,104

Bought: 0Sold: 1.16M

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 13, 2026	APLS Apellis Pharmaceuticals, Inc.	Chief Executive Officer	Sell	10,186	$22.19	$225,998.82	-3.1%	+91.2%	-
Aug 28, 2025	APLS Apellis Pharmaceuticals, Inc.	Chief Executive Officer	Sell	225,000	$28.23	$6,352,742.60	-25.3%	-23.0%	-
Jul 17, 2025	APLS Apellis Pharmaceuticals, Inc.	Chief Executive Officer	Sale+OE	19,725	$20.21	$398,734.96	-5.6%	+25.8%	-
Jul 15, 2025	APLS Apellis Pharmaceuticals, Inc.	Chief Executive Officer	Sale+OE	139,365	$20.19	$2,813,091.44	-16.9%	+24.8%	-
Jan 29, 2025	APLS Apellis Pharmaceuticals, Inc.	Chief Executive Officer	Sell	2,824	$29.52	$83,374.65	-0.7%	-38.2%	-21.8%
Jan 22, 2025	APLS Apellis Pharmaceuticals, Inc.	Chief Executive Officer	Sell	13,551	$30.43	$412,295.95	-3.1%	-42.8%	-27.6%
Jan 17, 2025	APLS Apellis Pharmaceuticals, Inc.	Chief Executive Officer	Sell	6,007	$29.96	$179,958.91	-2.0%	-39.2%	-33.4%
Jan 13, 2025	APLS Apellis Pharmaceuticals, Inc.	Chief Executive Officer	Sell	6,247	$28.70	$179,302.02	-2.0%	-32.4%	-25.4%
Mar 1, 2024	APLS Apellis Pharmaceuticals, Inc.	Chief Executive Officer	Sale+OE	250,000	$64.11	$16,028,705.81	-10.7%	-36.2%	-60.6%
Feb 12, 2024	APLS Apellis Pharmaceuticals, Inc.	Chief Executive Officer	Sell	3,962	$67.77	$268,492.46	-1.2%	-36.5%	-57.9%